Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5276640
Max Phase: Preclinical
Molecular Formula: C23H21N5OS
Molecular Weight: 415.52
Associated Items:
ID: ALA5276640
Max Phase: Preclinical
Molecular Formula: C23H21N5OS
Molecular Weight: 415.52
Associated Items:
Canonical SMILES: CCc1ccccc1-n1nc(-c2cn(C)c3ccccc23)cc1/N=C1/NC(=O)CS1
Standard InChI: InChI=1S/C23H21N5OS/c1-3-15-8-4-6-10-19(15)28-21(24-23-25-22(29)14-30-23)12-18(26-28)17-13-27(2)20-11-7-5-9-16(17)20/h4-13H,3,14H2,1-2H3,(H,24,25,29)
Standard InChI Key: JWMLMHKZKANXKL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 415.52 | Molecular Weight (Monoisotopic): 415.1467 | AlogP: 4.44 | #Rotatable Bonds: 4 |
Polar Surface Area: 64.21 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.94 | CX LogP: 5.27 | CX LogD: 5.05 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.54 | Np Likeness Score: -1.06 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):